ABIVAX Société Ownership
| AAVXF Stock | USD 5.89 0.00 0.00% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
ABIVAX |
ABIVAX Pink Sheet Ownership Analysis
About 57.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 2.59. ABIVAX Socit Anonyme had not issued any dividends in recent years. ABIVAX Socit Anonyme discovers and optimizes drugs for the treatment of inflammatory diseases, infectious diseases, and cancer in France. The company was incorporated in 2013 and is headquartered in Paris, France. Abivax Sa is traded on OTC Exchange in the United States.The quote for ABIVAX Socit Anonyme is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on ABIVAX Socit Anonyme please contact the company at 33 1 53 83 08 41 or go to https://www.abivax.com.Currently Active Assets on Macroaxis
Other Information on Investing in ABIVAX Pink Sheet
ABIVAX Société financial ratios help investors to determine whether ABIVAX Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ABIVAX with respect to the benefits of owning ABIVAX Société security.